PHOS W1 FINALS

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/97

encourage image

There's no tags or description

Looks like no tags are added yet.

98 Terms

1
New cards

USP 797 - This establishes a standard of practice for compounding sterile preparations.

This outlines the required procedures for compounding sterile preparations.

2
New cards

USP 797 - including hospital pharmacies, chemotherapy units, nuclear pharmacies, long-term care facilities, ambulatory care centers where there is a compounding sterile preparation activities

This applies to pharmacies that produce compounded sterile preparations

3
New cards

USP 797: Designed to protect both the patients and the pharmacists. Requires attention to three main areas to ensure compliance

Staff training and ongoing guidance Determination of the categories Development and implementation of appropriate policies and procedures

4
New cards

Parenteral Nutrition: also known as

Intravenous hyperalimentation

5
New cards

Parenteral Nutrition

Feeding of a patient by the intravenous infusion of fluids and basic nutrients (the delivery of nutrients is intravenous via the bloodstream)

6
New cards

Central Parenteral Nutrition

often called Total Parenteral Nutrition (TPN); delivered into a central vein

7
New cards

Peripheral Parenteral Nutrition (PPN)

delivered into a smaller or peripheral vein

8
New cards

Anticipated duration of parenteral nutrition

should be greater than or equal to 7 days (duration ≥ 7 days)

9
New cards

Total Parenteral Nutrition

IV administration of nutrients precisely formulated in such a manner that the totality of the patient's nutritional needs were satisfied.

10
New cards

Hypertonic solution - >300mOsm/L of dextrose and amino acids

It is designed to be a ____ so that the needed nutrients are provided in an amount of fluid that does not exceed the daily fluid capacity of the body

11
New cards

TPN: It was developed in ____, in the ____ — by ____

1960, University of Pennsylvania — by Dr. Stanley J. Dudrick, Dr. Jonathan E. Rhoads, Dr. Douglas Wilmore

12
New cards

TPN requires a ____ that empties into the superior or inferior vena cava

catheter or port

13
New cards

Total Nutrient Admixture or 3-in-1 or All-in-One Parenteral Nutrition

combination of carbohydrates, fats, and proteins - If lipid is added directly to the solution - Pre mixed: Vitrimix, Kabiven, Nutripack

14
New cards

2-in-1

combination of carbohydrates and proteins, the fat is separate

15
New cards

3-in-1 na nandito sa right side ng pic is Kabiven

Total Nutrient Admixture

16
New cards

Port of entry of TPN =

subclavian vein is the preferred port of entry because of reliable access points for temporary and permanent venous cannulation to support hemodynamic monitoring, fluid and medication administration, and parenteral nutrition. Also, the subclavian vein has low infection rate

17
New cards

Peripheral Parenteral Nutrition

Nutritional support that supplements oral intake and provide only part of the daily nutritional requirements. Patient needs IV nutritional support but does not have a central line Therapy is expected to be short term (10-14 days) Energy and protein needs are moderate It is given as a supplement to enteral feeding so the Formulation osmolarity is <600-900 mOsm/L Fluid restriction is not necessary

18
New cards

Goal of Therapy

To achieve adequate nutritional status and positive nitrogen balance until exercise and the utilization of nutrients via GIT is possible. Maintain weight and metabolic integrity Replete malnourished patients with deficits in lean body mass accompanied by deficits in visceral and serum proteins Restore hematologic and immune function integrity

19
New cards

Indication

Oral feeding is not feasible - Given intravenously to patients unable to assimilate nutrients via the GIT - Should be used only when the gut is not available Oral feeding is not enough - A patient with good nutritional reserves when it is anticipated that the GI tract will not be available for more than 7 days - The patient is severely malnourished or under moderate stress like if the patient underwent major surgery or its a ?? patient Oral feeding is not recommended - Especially for patients with nonfunctioning GI tract - If the patient has a severe malnutrition, short bowel syndrome, or intestinal obstruction. Oral feeding is dangerous - Patients who require bowel rest Can also be given to immunocompromised patients

20
New cards

PN is no value or little value:

Functional and accessible GI tract Patient is taking oral diet Good nutritional support Risk exceeds benefit End stage, terminally ill

21
New cards

TPN - Route of Administration

preferred nutritional supplement for a long time because it delivers through the central vein - comes in a higher concentration - can only be administered through a large vein such as the chest or neck

22
New cards

PPN - Route of Administration

only partially preferred because it is not safe to use hyperosmolar solutions in the peripheral vein for a very long time - comes in a lesser concentration - can be delivered to the peripheral vein

23
New cards
  1. PERIPHERAL ROUTE

Dextrose concentration: - NMT 10% for adults and 12.5% for children - Because the osmolality of higher dextrose concentrations can cause phlebitis of peripheral veins - phlebitis - inflammation of the vein Amino acid: - Limited to a maximum of 5% in adults and 3.5% in children Advantages: - Simple, straight forward procedure Disadvantage: - Hypertonic solutions will cause thrombophlebitis and severe tissue necrosis Management: - Keep infusion site visible for regular inspection not concealed in dressing - Should be regularly re-sited, particularly in infants. - Must be changed at least every 3 days or when phlebitis occurs - Place infusion site where extravasation injuries are less disfiguring - Follow established protocols for dressing & management of ward. - Some add hydrocortisone 5mg/day, heparin 100-1000 units/day to help reduce phlebitis occurrence

24
New cards

phlebitis

inflammation of the vein

25
New cards
  1. CENTRAL ROUTE

via femoral lines, internal jugular lines, and subclavian vein catheters Advantages: - No complications of thrombophlebitis or extravasation Disadvantages: - Catheter-related sepsis Management: - Requires scrupulous aseptic technique at all times by a trained staff

26
New cards

CENTRAL ACCESS

required for infusions that are toxic to small veins due to the pH, osmolarity, and volume of the medication

27
New cards

PICC Lines (Peripherally Inserted Central Catheter)

May be used in ambulatory settings or for long term therapy Used for delivery of medication as well as PN Via cephalic, basilic, median basilic, or median cephalic veins and threaded into the superior vena cava Can remain in place for up to 1 year with proper maintenance and without complications

28
New cards

Macronutrients: Carbohydrate

Source: - Dextrose 50% or 70% - 3.4kcal/g Properties: Energy source Final dextrose concentration: - Central Vein - ~25% - Peripheral Vein - maximum of 10-12.5%

29
New cards

Macronutrients: Proteins

Source: - Crystalline amino acids — standard or specialty - 8.5%, 10%, 15% Properties: 4.0 kcal/g Example (pic): amino acid - Aminoleban® solution and Aminoleban® ORAL (orange flavored powder)

30
New cards

Macronutrients: Lipids

Source: - Lipofundin 10%, 20%, Liposyn, Intralipids Properties: 10 kcal/g Prevents essential fatty acid deficiency Lipids supply a large percentage of energy requirements. This may be given separately or in solution to minimize the development of phlebitis. To prevent hyperlipidemia, lipid emulsions are not provided continuously - to give the body to clear the lipids in the blood. It is generally administered at least 2 to 3 times a week, but it can be provided daily.

31
New cards

Micronutrients: Fluids

Source: - Sterile water for injection - To meet fluid requirements Recommended intake: - 30 to 50 mL/kg (1.5 to 3 L/day)

32
New cards

Micronutrients: Electrolytes

Source: - Generally present in most foods - To meet daily metabolic needs - Na, K, Cl, Ca - NaCl, Na3PO4, KCl, Ca gluconate, Ca acetate, MgSO4 Electrolytes are calculated based on the health status of the patient

33
New cards

Sodium (Na)

helps control distribution and maintain the normal fluid balance.

34
New cards

Potassium (K)

is needed for cellular activity and tissue synthesis.

35
New cards

Magnesium (Mg)

helps absorb carbohydrates and proteins.

36
New cards

Calcium (Ca)

is needed for bone and teeth developments. Also aids in clotting.

37
New cards

Phosphate (PO4)

plays a crucial role in metabolic pathways

38
New cards

Chlorine (Cl)

regulates the acid-base equilibrium and maintains osmotic pressure.

39
New cards

Micronutrients: Vitamins

Essential in the metabolism of CHO, CHON & fats - CHO - carbohydrates - CHON - proteins Vit. B & C Vit. A, D, E, & K - Added once and twice a week MVI - multiple vitamin infusion - Example (pic) - MULTIDEX - commercially prepared multivitamins + dextrose

40
New cards

Vit. A

helps maintain integrity of the skin; essential to vision

41
New cards

Vit. B

needed in the absorption of carbohydrates and proteins

42
New cards

Vit. C

helps in wound healing

43
New cards

Vit. D

essential for bones and maintenance of serum calcium levels

44
New cards

Vit. K

prevents bleeding disorders

45
New cards

Micronutrients: Trace Elements

For proper enzymatic reactions Zn, Cu, Mn, Cr Iron - not routinely added because it changes the pH of the solution - iron supplementation should be limited to conditions of iron deficiency Helps in wound healing and red blood cell synthesis Reduction in manganese and copper dosing should be considered in patients with hepatobiliary disease due to impaired excretion

46
New cards

Nutrition Support Team

In order to assure patients of maximum efficient and proper nutrition support for their nutritional needs

47
New cards

Nutrition Support Team: Objectives

To standardize the practice of providing nutritional support to hospitalized patients. To centralize all activities regarding nutritional support to a team of experts. To recommend policies and guidelines to the hospital regarding proper and up-to-date practices in nutritional support of patients. To provide expert advice and consult to physicians needing help in the nutritional support of their patients.

48
New cards

Nutrition Support Team: Members

Physician - Chairman of NST Nurse Pharmacist Dietician Physical Therapist Social worker Medical Technologist

49
New cards

NST Member: Physician - Chairman of NST

Clinical decision regarding the safety and effectiveness of TPN therapy Identifies the candidates for TPN therapy Reviews the nutritional assessment data Responsible for catheter placement Prescribes appropriate formulations to be compounded by the pharmacists Establish goals of therapy Directs patient monitoring

50
New cards

NST Member: Nurse

Reassure the patient about the procedure Gathers necessary items for catheter placement Prepares patient - emotionally and physically for the procedure to be done Assist the physician in the insertion of the catheter Arranges the appropriate IV apparatus Takes charge of the maintenance of the catheter site Cares for the catheter site Participates in patient monitoring

51
New cards

NST Member: Pharmacist

Prepares parenteral nutrition Knowledge of additive compatibility or incompatibility and drug interactions Inform the physician if there is any suspected errors in the ordering of parenteral nutrition. Inform the physician of the need for the substitute drugs. Knowledge of various TPN substrates

52
New cards

NST Member: Dietician

Helps in the patient's nutritional assessment Enteral feeding Manages the transitional feedings from parenteral to enteral route.

53
New cards

NST Member: Physical Therapist

Exercise program designer

54
New cards

NST Member: Social worker

Emotional and financial support

55
New cards

NST Member: Medical Technologist

Laboratory tests

56
New cards

Clinical Management

Start slowly, increased gradually; and end vice-versa - start TPN slowly so that the body will have the time to adapt to both of the glucose load and the hyperosmolarity of the solution, to avoid the fluid overload Choice of administration route depends on final osmolarity of mixture Clinical monitoring is required at the start of any infusion. Any abnormalities, the infusion is stopped. Frequent clinical evaluation and laboratory tests are necessary for correct monitoring during drug administration. IV flow rate should be maintained with 20% of that ordered. Any sustained rapid increase in fluid infusion can cause hyperglycemia, glucosuria, and osmotic diuresis. Vital signs should be taken every 4 hours around the clock. Weigh daily. Any weight gain in excess of ½ pound per day may be due to excess fluid retention. Use same scale, same time, with similar articles of clothing. Catheter is changed every other day or when clinically indicated. Patient should be ambulated when possible. Exercise enhances the achievement of N balance and restitution of muscle mass.

57
New cards

Additive Compatibility

Do not add antibiotics, steroid, and pressor agents. - in the parenteral nutrition Na bicarbonate is not compatible with Ca or MgSO4 High dextrose + whole blood = clumping of RBC’s Vitamin K is activated by Vitamin C in solution Ca gluconate may cause false depression in serum and urine Mg levels when Titan yellow method for determining Mg is used. Insulin in TPN is effective, but it may be unstable in the presence of Na bicarbonate. Physical separation may occur if not mixed thoroughly. Albumin - visually compatible for 24 hours, but increase risk for fungal and bacterial growth. Occlusion of filters occur if concentration of Albumin exceeds 25 g/L. Lipids, infused by Y - line near the infusion site. - Lipid emulsion obscure the presence of precipitate, therefore if a lipid emulsion is needed, it would be infused separately

58
New cards

Additive Compatibility (Sidenotes)

when adding calcium or phosphate to an admixture, phosphate should be added first to prevent precipitation during the mixing process, the pharmacist should periodically agitate the mixture and check for the presence of precipitates before and during the infusion

59
New cards

Pharmaceutical Precautions

Store below 25°C. Do not freeze - if stored in a room temperature, infusion should be started within 24 hours after mixing - if refrigerated, should be started within 24 hours after rewarming once administration begin - once administration begin, care should be taken to avoid excess rewarming of the admixture - excessive rewarming of the admixture may sometimes cause precipitation Do not administer simultaneously with, before and after an administration of blood through the same infusion equipment due to pseudoagglutination Once prepared, use immediately or refrigerate. Remove from refrigeration 1 hour prior to infusion to reach approximately room temperature. - there is a rewarming Once hung, must be infused or discarded within 24 hours. - if not used No medications should be added to TPN lines once they are infusing, except lipid emulsion.

60
New cards

TPN Form

Preprinted order forms Reduce error May be required in some hospitals - Each facility designs components of preprinted forms

61
New cards

TPN Form (Sidenotes)

in initiating parenteral nutrition, the parenteral nutrition or the ring system should be established in every hospital, in every institution to uniformly reduced prescription error TPN form should be properly/clearly filled out and should be understandable to anyone who will utilize the form the design of the preprinted forms depends on the institution or the facility important/necessary information should be indicated (e.g. route of administration, the rate and the time of infusion, ingredients, concentration) should be organized so that it can be easily scan for any errors

62
New cards

INITIATING PARENTERAL NUTRITION

Start slow: 1 L - 1st day; 2 L - 2nd day Infusion rate may be increased as glucose tolerance permits Maximum amount of protein on the first day - up to 60-70 grams/liter - as proteins are associated with the few metabolic side effects Maximum CHO given on the first day: 150-200 g/day or a 15-20% final dextrose concentration Glucose intolerance, 100-150 g dextrose or 10-15% glucose concentration If 24 hr TPN is to be discontinued, the rate of administration is slowed to prevent rebound hypoglycemia (especially for infants and children) Parenteral nutrition is discontinued when enteral or oral intake achieves ⅔ of the patient’s estimated needs. Generally energy and protein needs can be met in adults by day 2 or 3 In neonates and pediatrics, time to reach full support relates inversely to age, may be 3-5 days

63
New cards

CONTINUOUS PN

Non-interrupted infusion of a PN solution over 24 hours via a central or peripheral venous access It is infused at a constant rate controlled by a pump Advantages: - Well tolerated by most patients - Requires less manipulation - ↓ nursing time - ↓ potential for “touch” contamination Disadvantages: - Persistent anabolic state - altered insulin : glucagon ratios - increased lipid storage by the liver - Reduces mobility in ambulatory patients

64
New cards

CYCLIC PN

Intermittent administration via a central or peripheral venous access, usually over a period of 12 - 18 hours Patients on continuous therapy may be converted to a cyclic PN over 24-48 hours Advantage: - Approximates normal physiology of intermittent feeding - Maintains: - Nitrogen balance - Visceral proteins - Ideal for ambulatory patients - Allows normal activity - Improves quality of life Disadvantage: - Incorporation of N2 into muscle stores may be suboptimal - Nutrients administered when patient is less active - Not tolerated by critically ill patients - Requires more nursing manipulation - Increased potential for touch contamination - Increased nursing time

65
New cards

Cyclic PN (Sidenotes)

intermittent - occurring in irregular interval if the patient is to nourished with TPN for an extended period of time, cyclic PN is employed if the patient is fed during the night and fasting during the day, cyclic PN is employed cyclic PN helps prevent hepatotoxicity that can be developed on a long-term used the fasting period allows the fatty acids to be released from the fat store

66
New cards

Aseptic Preparation

Involves procedures designed to preclude contamination by microorganisms during processing.

67
New cards

Aseptic Preparation - there is a free from contamination

Ability of the personnel to handle the sterile components of these IV solutions in the clean environment of a Laminar flow hood without introducing viable microorganisms in the product.

68
New cards

Aseptic Preparation (procedures)

Thorough hand-washing with appropriate antimicrobial. Wearing of protective clothing, mask, head cover, shoes and gloves. - remove all makeup, no jewelries, do not touch the face and the hair Disinfection of non-sterile materials to be used.

69
New cards

Sources of product contamination

People (most common) - Touch contamination - Generation of particulates from shedding cells or hair Air supply - Heating Ventilation and Air Conditioning (HVAC) Infiltration - Particles from adjacent spaces (e.g. anteroom) Internal generation - Walls, floors, ceilings, packaging, equipment

70
New cards

Importance of Aseptic Technique

Parenteral administration bypasses the skin and gastrointestinal tract, the bodies natural barriers to infection Giving a patient a contaminated product can cause serious adverse effects including DEATH Parenteral medications account for >40% of all medications administered in institutional practice - that is why we really have to practice aseptic technique in a hospital

71
New cards

Laminar Flow Workbenches: Principle

Constant flow of HEPA filtered air Continuously sweeps the work area Prevents the entry of contaminated air

72
New cards

HEPA filter

High Efficiency Particulate Air filter removes 99.97% of all air particles 0.3mm or larger

73
New cards

Horizontal LAFW (Laminar Flow Hood) Vertical LAFW (biological safety cabinets (BSCs or Chemotherapy Hood)

Laminar Flow Workbenches: 2 Types

74
New cards

Horizontal LAFW (Laminar Flow Hood)

Air moves from back to front Used for non-chemotherapy preparations Most common for sterile preparations of IV solutions Should be cleaned or replaced on regular basis Entire back portion of hood’s work area is HEPA Removes 99.97% of particles that are 0.3 micron or larger - the hood prevents contamination of compounded sterile products and parenteral preparations

75
New cards

Vertical LAFW (biological safety cabinets (BSCs or Chemotherapy Hood)

Air emerges from the top and passes downward Exposure to airborne drug particles minimized Used for preparation of antineoplastics Must prevent downstream contamination Zone of turbulence - air turbulence created inside the critical area by introduction of an object in a direct path - could potentially extend outside the hood pulling/allowing contaminated air into the aseptic work area - the BSC is designed to protect the pharmacist, pharmacy technician, or anyone who will prepare the preparation from exposure to hazardous medications

76
New cards

Zone of turbulence

air turbulence created inside the critical area by introduction of an object in a direct path - could potentially extend outside the hood pulling/allowing contaminated air into the aseptic work area

77
New cards

Zone of turbulence (sidenote)

when the laminar airflow is moving on all sides of the object, the zone of turbulence extends 3 times the diameter of the object but if the laminar airflow is not accessible to both sides of the object, the zone of turbulence extends 6 times the diameter of the object

78
New cards

Laminar flow hood (sidenote)

it is advisable to work with objects 6 inches from the side and front edge without blocking the bench(?)

79
New cards

6 inches - to prevent the possibility of contamination from room air and tiring(?) a hood

All aseptic manipulations should be performed at least ____ within the hood.


80
New cards

15-30 minutes

Hood: Must run for ____ if turned off and back on

81
New cards

All interior working surfaces should be cleaned

70% isopropyl alcohol/other disinfecting agent Clean, lint-free cloth

82
New cards

Clean Room

Specifically constructed room in which the air supply, air distribution, dust and airborne particles, room pressure, temperature and humidity are environmentally regulated to meet appropriate cleanliness level.

83
New cards

Aseptic preparation

Demands meticulous “NO - TOUCH” technique, EVERY TIME! Aseptic technique requires specific manipulations for: - Syringes - Needles - Vials - Ampules - Removal of packaging - Assembling of sterile products - Hand placement

84
New cards

Aseptic preparation: Syringe

NEVER TOUCH Tip or Plunger Open syringe package in hood Peel wrapper and discard out of hood Leave syringe tip protector in place until time to attach needle To attach needle to Luer-lock-type syringe ¼ turn is usually sufficient to secure needle to syringe

85
New cards

Coring

The development of a core or hole in the rubber of a vial - To prevent coring insert needle as shown - Insert the bevel tip first, then pressing downward and toward the bevel so the bevel tip and heel enter at the same point

86
New cards

Needle size is determined by two numbers

Gauge Length

87
New cards

The larger the gauge number

the finer the diameter of the needle’s bore - 27 gauge needle finer than 13 gauge needle - Common needle sizes at UK include - 16G 1&½ inch - 18G 1&½ inch - 20G 1 inch

88
New cards

gauge

is the outer diameter of the needle

89
New cards

Needles and syringes (sidenotes)

it is important that when using needles and syringes in product preparation, they are not to be removed from the hood workspace needles and syringes, after using, must be properly disposed in the sharp container located near the hood to prevent injury to others NEVER disposed needles and syringes in a regular trash

90
New cards

Aseptic preparation: Vials and Ampules - To prevent contamination

Swab rubber closure with 70% alcohol using firm strokes in the SAME direction

91
New cards

Aseptic preparation: Vials and Ampules - To prevent core formation

Insert needle to penetrate the rubber closure at same point with both tip and heel of bevel

92
New cards

Aseptic preparation: Vials and Ampules - To prevent vacuum formation

Inject an equal amount of air for the volume of fluid to be removed

93
New cards

Aseptic preparation: Vials and Ampules - Reconstituting drug powder

Remove an equal amount of air for the volume of diluent added

94
New cards

Aseptic preparation: Vials and Ampules - To break ampule

Clean ampule neck with alcohol swab Leave swab in place Grasp ampule neck with thumb and index finger Use quick, firm, snapping motion away from body towards side wall of hood DO NOT BREAK TOWARD HEPA FILTER

95
New cards

tilt the ampule break the neck place the bevel in the corner space near the opening pull back the syringe plunger

to withdraw medication from the ampule

96
New cards

filter needle can only be used in one direction

to avoid glass contamination of ampule solution, use 5 micron filter needle to filter glass as solution is push out of the syringe

97
New cards

Aseptic preparation: Removing Packaging

Any sterile component or supply (e.g., syringes, needles, and ampules) should only be opened and/or removed from their packaging within the laminar-flow workspace. When opening the wrapper on a needle, it should be peeled open. Tearing paper introduces paper particles into the hood which could lead to product contamination. - no tearing of paper inside the hood

98
New cards

Beyond-Use Date

Beyond-use date based where the compounded preparation is being made: Category 1 Facility (PEC/C-PEC located in an SCA or C-SCA) beyond use date (BUD) is: - primary engineering control - 12 hours or less at controlled room temperature - 24 hours or less when refrigerated Category 2 Facility (located in a Buffer Room with an anteroom) beyond use date can be: - Greater than 12 hours at controlled room temperature - Greater than 24 hours when refrigerated The chemical stability of some drugs may be shorter than the default BUDs - the pharmacists should keep this in mind